Cargando…
Concomitant Inhibition of Cytoprotective Autophagy Augments the Efficacy of Withaferin A in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality, and despite recent advances in early diagnosis and therapeutics, HCC related morbidity and mortality rate continue to rise. Clearly, it is imperative to develop novel effective therapies for HCC to improve lon...
Autores principales: | Siddharth, Sumit, Muniraj, Nethaji, Saxena, Neeraj K., Sharma, Dipali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521104/ https://www.ncbi.nlm.nih.gov/pubmed/30934990 http://dx.doi.org/10.3390/cancers11040453 |
Ejemplares similares
-
Concomitant activation of ETS-like transcription factor-1 and Death Receptor-5 via extracellular signal-regulated kinase in withaferin A-mediated inhibition of hepatocarcinogenesis in mice
por: Kuppusamy, Panjamurthy, et al.
Publicado: (2017) -
Induction of STK11-dependent cytoprotective autophagy in breast cancer cells upon honokiol treatment
por: Muniraj, Nethaji, et al.
Publicado: (2020) -
Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer
por: Muniraj, Nethaji, et al.
Publicado: (2019) -
Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression
por: Siddharth, Sumit, et al.
Publicado: (2021) -
Metformin Enhances the Anti-Cancer Efficacy of Sorafenib via Suppressing MAPK/ERK/Stat3 Axis in Hepatocellular Carcinoma
por: Siddharth, Sumit, et al.
Publicado: (2022)